Photo of Brian K. Fitzpatrick
R United States House · District 1 · Pennsylvania On the 2026 ballot

Rep. Brian K. Fitzpatrick

Compare
Total votes
2,837
all sessions
Attendance
100%
9 missed
Higher than 75% of chamber peers
With party
76%
of cast votes
Lower than 98% of chamber peers
Bipartisan score
12%
some cross-party votes
Higher than 97% of chamber peers
Sponsored
4,059
bills & resolutions
Higher than 99% of chamber peers
Committees
6
assignments
4,059 bills and resolutions

Sponsored bills

Total
4,059
Primary
180
Co-sponsor
3,879
This page
4,059
matching current filters
Co-sponsor HR 3848
In committee · United States House · Co-sponsor
Critical Supply Chains Commission Act

Critical Supply Chains Commission Act This bill establishes a National Commission on Critical Supply Chains to identify and investigate the dependencies, limitations, and risks associated with critical supply chains. The commission may hold hearings as appropriate and obtain relevant information directly from federal, state, and local governmental bodies as needed. The commission must annually report its findings, conclusions, and recommendations for actions to mitigate the risks of future American supply chain disruptions.

In committee Jun 14, 2021 1 co-sponsor
Co-sponsor HR 3808
In committee · United States House · Co-sponsor
Medicare IVIG Access Enhancement Act

Medicare IVIG Access Enhancement Act This bill requires the Centers for Medicare & Medicaid Services to establish a five-year demonstration project to evaluate the benefits of providing Medicare coverage and payment for items and services needed for the in-home administration of intravenous immune globulin to treat chronic inflammatory demyelinating polyneuropathy or multifocal motor neuropathy. Beneficiary participation shall be voluntary.

In committee Jun 14, 2021 1 co-sponsor
Co-sponsor HR 3831
In committee · United States House · Co-sponsor
Seniors Securing Access to Vital and Essential Prescription Drugs Act

Seniors Securing Access to Vital and Essential Prescription Drugs Act This bill alters certain financial standards that are used to determine eligibility for the low-income subsidy program under the Medicare prescription drug benefit. Specifically, the bill excludes certain retirement plans from income and resource determinations.

In committee Jun 14, 2021 1 co-sponsor
Co-sponsor HR 3853
In committee · United States House · Co-sponsor
Pink Tax Repeal Act

Pink Tax Repeal Act This bill prohibits product manufacturers or service providers from selling substantially similar products at different prices based on the gender of the intended purchaser. If, for example, the only difference between two products is the color, they are substantially similar. The bill provides authority for the Federal Trade Commission and state attorneys general to enforce these requirements.

In committee Jun 14, 2021 1 co-sponsor
Co-sponsor HR 3855
In committee · United States House · Co-sponsor
Accounting STEM Pursuit Act of 2021

Accounting STEM Pursuit Act of 2021 This bill authorizes states and local educational agencies (LEAs) to use grant funds provided through the Student Support and Academic Enrichment Program for accounting education. In particular, LEAs may use these grant funds to implement programs to teach accounting, including by increasing access to high-quality accounting courses through 12th grade for students who are members of underrepresented groups.

In committee Jun 11, 2021 1 co-sponsor
Co-sponsor HR 3761
In committee · United States House · Co-sponsor
Promising Pathway Act

Promising Pathway Act This bill establishes a provisional approval pathway for medicines intended for serious or life-threatening diseases, including illnesses posing a threat of epidemic or pandemic. The period of the provisional approval is for two years and is potentially renewable. The Food and Drug Administration (FDA) must establish a priority review system to evaluate completed provisional approval applications within 90 days of receipt. A provisional approval application may be approved if the FDA determines that (1) there is substantial evidence of safety for the drug; and (2) there is relevant early evidence of efficacy, based on adequate and well-controlled investigations. During the COVID-19 (i.e., coronavirus disease 2019) pandemic, or another epidemic or pandemic, the FDA must accept and review various portions of a provisional approval application on a rolling basis. The manufacturer of a provisionally approved drug must require patients to participate in an observational registry. A manufacturer that fails to comply with registry requirements is subject to civil penalties. A provisionally approved drug must be labeled as such. If a drug that receives provisional approval status is not brought to market within 180 days of the approval, the approval must be rescinded. The bill also limits the liability of a manufacturer of a provisionally approved drug with respect to any claim under state law alleging that the drug is unsafe or ineffective. Private health insurers and federal health care programs shall not deny coverage of a provisionally approved drug on the basis of it being experimental.

In committee Jun 9, 2021 1 co-sponsor
Co-sponsor HR 3773
In committee · United States House · Co-sponsor
PACT Act of 2021

Pediatricians Accelerate Childhood Therapies Act of 2021 or the PACT Act of 2021 This bill requires the National Institutes of Health (NIH) to make awards to support early-career pediatric researchers. It also provides statutory authority for the Trans-NIH Pediatric Research Consortium to coordinate pediatric research across national health research institutions.

In committee Jun 9, 2021 1 co-sponsor
Co-sponsor HR 3759
In committee · United States House · Co-sponsor
Physical Therapist Workforce and Patient Access Act of 2021

Physical Therapist Workforce and Patient Access Act of 2021 This bill makes physical therapists eligible for the National Health Service Corps Loan Repayment Program. This program assists primary care, mental health, and dental providers in repaying eligible student loans in exchange for working in areas with shortages of such providers.

In committee Jun 9, 2021 1 co-sponsor
Co-sponsor HR 3776
In committee · United States House · Co-sponsor
BUILD Veterans Businesses Act of 2021

Better Utilizing Infrastructure for Lasting Development of Veterans Businesses Act of 2021 or the BUILD Veterans Businesses Act of 2021 This bill requires a specified percentage of certain Federal-aid highway and public transportation funds to be expended through veteran-owned small businesses.

In committee Jun 9, 2021 1 co-sponsor
Co-sponsor HR 3783
In committee · United States House · Co-sponsor
Medical Nutrition Equity Act of 2021

Medical Nutrition Equity Act of 2021 This bill expands coverage under Medicare, Medicaid, other specified federal health care programs, and private health insurance to include foods, vitamins, and individual amino acids that are medically necessary for the management of certain digestive and metabolic disorders and conditions.

In committee Jun 9, 2021 1 co-sponsor
Showing 3,601 to 3,610 of 4,059 bills